Ruyi Lei

Title: Ruyi Lei: Innovator in Antibacterial and Immunomodulatory Agents

Introduction

Ruyi Lei is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial and immunomodulatory agents. His innovative work has led to the creation of a unique variant of human alpha-defensin 5, which has promising applications in medicine.

Latest Patents

Ruyi Lei holds a patent for a human alpha-defensin 5 variant and its uses. This variant is obtained by adding amino acid residues at the C-terminal of alpha-defensin 5 and modifying it to link an aliphatic acid. The modification enhances the antibacterial activity and salt tolerance of the peptide, making it a valuable asset in the development of new therapeutic agents. The variant can significantly promote the release of inflammatory factors from macrophages, indicating its potential use in immunomodulatory applications. He has 1 patent to his name.

Career Highlights

Ruyi Lei is affiliated with Zhejiang University, where he conducts research and develops innovative solutions in the field of biotechnology. His work has garnered attention for its potential to address significant health challenges through the use of modified peptides.

Collaborations

Ruyi Lei collaborates with esteemed colleagues, including Qixing Chen and Baoli Cheng, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the scientific community.

Conclusion

Ruyi Lei's contributions to the field of biotechnology, particularly through his patented human alpha-defensin 5 variant, highlight his role as an innovator in developing new antibacterial and immunomodulatory agents. His work at Zhejiang University continues to pave the way for advancements in medical applications.